ArticleNaunyn-Schmiedeberg's archives of pharmacology2007

Anticholinergic antiparkinson drug orphenadrine inhibits HERG channels: block attenuation by mutations of the pore residues Y652 or F656.

Eberhard P Scholz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.